Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3

Joerg Betschinger1, Jennifer Nichols, Sabine Dietmann

  • 1Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge CB2 1QR, UK. jb579@cam.ac.uk

Cell
|April 16, 2013
PubMed

Insights

Tumor suppressors Folliculin (Flcn) and Tsc2 prevent embryonic stem cell (ESC) commitment by regulating Tfe3. Enforced nuclear Tfe3 maintains pluripotency, revealing a rheostat for lineage commitment.

Area of Science:

  • Stem cell biology
  • Molecular mechanisms of pluripotency
  • Cell fate determination

Background:

  • Self-renewal of mouse embryonic stem cells (ESCs) is well-understood.
  • The molecular machinery controlling exit from pluripotency remains poorly defined.

Purpose of the Study:

  • To identify factors regulating exit from pluripotency in ESCs.
  • To elucidate the role of Folliculin (Flcn) and Tsc2 in ESC commitment.

Main Methods:

  • Large-scale small interfering RNA (siRNA) screen.
  • Analysis of mammalian target of rapamycin (mTOR) pathway.
  • Investigation of transcription factor Tfe3 localization and activity.
  • Genome-wide location and functional analyses.
  • In vivo studies of epiblast development.

Main Results:

  • Knockdown of Flcn and Tsc2 prevents ESC commitment.
  • Flcn, with Fnip1/2, restricts nuclear Tfe3, promoting differentiation.
  • Enforced nuclear Tfe3 allows ESCs to resist differentiation.
  • Tfe3 directly regulates Esrrb, integrating into the pluripotency circuitry.
  • Flcn-Fnip1/2 influences Tfe3 localization during in vivo development.

Conclusions:

  • Flcn-Tsc2-mTOR pathway and Flcn-Fnip1/2-Tfe3 axis act as a cell-intrinsic rheostat for pluripotency destabilization.
  • Tfe3 is a key regulator integrating pluripotency and differentiation.
  • Flcn-mediated regulation of Tfe3 is crucial for developmental progression of the epiblast.

Related Concept Videos

Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...